World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
74
Citations
18349
World Ranking
2062
National Ranking
1006

Sugantha Govindarajan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Sugantha Govindarajan sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 193 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Sugantha Govindarajan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Sugantha Govindarajan sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 74 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Sugantha Govindarajan is affiliated with the University of Southern California in the United States. Their research spans the fields of Medicine and Engineering, with focused contributions in subfields such as Hepatology, Epidemiology, Civil and Structural Engineering, Oncology, and Building and Construction. The scientist has published studies in topics including Hepatitis B Virus Studies, Hepatitis Viruses Studies and Epidemiology, innovative materials for concrete reinforcement, chitinases and chitosanases, phytase applications, and peptidase inhibition and analysis.

Recent publications attributed to Govindarajan highlight a diverse scientific interest. These include:

  • "Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis" (2021) published in Proceedings of the National Academy of Sciences
  • "Distinct disease features in chimpanzees infected with a precore HBV mutant associated with acute liver failure in humans" (2020) published in PLoS Pathogens
  • "A critical analysis of compressive strength prediction of glass fiber and carbon fiber reinforced concrete over machine learning models" (2025) published in Multiscale and Multidisciplinary Modeling Experiments and Design
  • "Development of lightweight high-strength engineered geopolymer composites using slag waste and vermiculite powder: mechanical, durability and microstructural assessments" (2025) published in Emergent Materials
  • "Liver biopsy and histopathological diagnosis" (2022) included in Yamada's Textbook of Gastroenterology

Frequent co-authors who have collaborated with Govindarajan include Norihisa Nishimura, Ronald E. Engle, Hanh Nguyen, Kevin W. Bock, and Ian N. Moore.

Govindarajan's contributions have been published across several scientific venues, often focusing on topics related to liver disease, pathology, and engineering materials. Regular publication outlets encompass:

  • Proceedings of the National Academy of Sciences
  • PLoS Pathogens
  • Multiscale and Multidisciplinary Modeling Experiments and Design
  • Emergent Materials
  • Yamada's Textbook of Gastroenterology

Best Publications

  • Lack of protective immunity against reinfection with hepatitis C virus

    Patrizia Farci;Harvey J. Alter;Sugantha Govindarajan;Doris C. Wong

  • Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

    Robert Thimme;Jens Bukh;Hans Christian Spangenberg;Stefan Wieland

  • Genetic and Experimental Evidence for Cross-Species Infection by Swine Hepatitis E Virus

    Xiang-Jin Meng;Patrick G. Halbur;Max S. Shapiro;Sugantha Govindarajan

  • Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization.

    Patrizia Farci;Harvey J. Alter;Doris C. Wong;Roger H. Miller

  • Synthesis of a novel hepatitis C virus protein by ribosomal frameshift

    Zhenming Xu;Jinah Choi;T. S.Benedict Yen;Wen Lu

  • Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity

    Zhang-Xu Liu;Sugantha Govindarajan;Neil Kaplowitz

  • Molecular cloning and sequencing of a human hepatitis delta (δ) virus RNA

    Shinji Makino;Ming Fu Chang;Chien Kou Shieh;Toshio Kamahora

  • The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences

    Akito Sakai;Marisa St. Claire;Kristina Faulk;Sugantha Govindarajan

  • Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection

    M Bonacini;G Hadi;S Govindarajan;K L Lindsay

  • Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees

    Jens Bukh;Thomas Pietschmann;Volker Lohmann;Nicole Krieger

  • Fulminant B viral hepatitis: role of delta agent.

    Sugantha Govindarajan;Kenneth P. Chin;Allan G. Redeker;Robert L. Peters

  • Successful passive and active immunization of cynomolgus monkeys against hepatitis E.

    S. A. Tsarev;T. S. Tsareva;S. U. Emerson;Sugantha Govindarajan

  • Liver Fibrosis Progression Is Related to CD4 Cell Depletion in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus

    Massimo Puoti;Maurizio Bonacini;Angiola Spinetti;Valeria Putzolu

  • Nonviral Risk Factors for Hepatocellular Carcinoma in a Low-Risk Population, the Non-Asians of Los Angeles County, California

    Mimi C. Yu;Brian E. Henderson;Myron J. Tong;Sugantha Govindarajan

  • Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog

    Keigo Machida;Hidekazu Tsukamoto;Hasmik Mkrtchyan;Lewei Duan

  • Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity.

    Ming-Fu Chang;S. C. Baker;L. H. Soe;T. Kamahora

  • Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element.

    S. U. Emerson;M. Zhang;X.-J. Meng;H. Nguyen

  • Epidemiology of Hepatocellular Carcinoma

    Mimi C Yu;Jian-Min Yuan;Sugantha Govindarajan;Ronald K Ross

  • Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees

    Xavier Forns;Robert Thimme;Sugantha Govindarajan;Suzanne U. Emerson

  • Prevalence of Hepatitis B and C Viral Markers in Black and White Patients With Hepatocellular Carcinoma in the United States

    Mimi C. Yu;Myron J. Tong;Pierre Coursaget;Ronald K. Ross

  • Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.

    James E. Everhart;Elizabeth C. Wright;Zachary D. Goodman;Jules L. Dienstag

Frequent Co-Authors

Robert H. Purcell
Robert H. Purcell National Institute of Allergy and Infectious Diseases
Suzanne U. Emerson
Suzanne U. Emerson National Institute of Allergy and Infectious Diseases
Ronald E. Engle
Ronald E. Engle National Institute of Allergy and Infectious Diseases
Patrizia Farci
Patrizia Farci National Institutes of Health
Jens Bukh
Jens Bukh University of Copenhagen
Mimi C. Yu
Mimi C. Yu University of Southern California
Jian-Min Yuan
Jian-Min Yuan University of Pittsburgh
Michael M. C. Lai
Michael M. C. Lai Academia Sinica
Gunther Dennert
Gunther Dennert University of Southern California
David E. Kleiner
David E. Kleiner National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology can open doors to various healthcare careers, many of which increasingly offer online educational options. For those looking to transition into nursing without a prior background, exploring online accelerated nursing programs for non nurses can provide a fast and flexible pathway into the field.

Students seeking less competitive entry points might find programs like the easiest ABSN to get into particularly appealing, as these programs balance accessibility with quality education to efficiently prepare future registered nurses.

For those considering entering nursing at a practical level, the fastest and easiest LPN programs offer practical nursing credentials that can serve as stepping stones to advanced degrees or immediate workforce entry.

Further advancement is possible through specialized roles like nurse practitioners. Researching the easiest nurse practitioner degree programs can help prospective students identify manageable, high-quality options tailored to their career goals.

By understanding these related online degree pathways, immunology students and professionals can strategically plan their education and career trajectory in the evolving healthcare landscape.

Best Scientists Citing Sugantha Govindarajan

Trending Scientists

Recently Published Articles